- Exchange: SIX Swiss Ex
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Addex Pharmaceuticals Ltd
Add to PortfolioADXN:SW
8.28 CHF 0.52 6.70%As of 11:31:34 ET on 05/25/2012.
Snapshot for Addex Pharmaceuticals Ltd (ADXN)
| Open: | 7.81 | Day's Range: | 7.81 - 8.28 | Volume: | 5,878 | Bid: | 8.02 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 7.76 | 52wk Range: | 5.00 - 12.70 | 1-Yr Rtn: | -21.52% | Ask: | 8.28 |
Key Statistics for ADXN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (CHF) (ttm) | -4.1900 |
| Est. EPS (CHF) (12/2012) | -1.3700 |
| Est. PEG Ratio | - |
| Market Cap (M CHF) | 64.88 |
| Shares Outstanding (M) | 7.84 |
| Enterprise Value (M CHF) (ttm) | 28.82 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 1.8855 |
| Price/Sale (ttm) | 21.7919 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/27/2012 |
More ADXN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for ADXN
- Operating
- Investing
- Financing (M/CHF)
Company Profile & Key Executives for ADXN
Addex Pharmaceuticals Ltd is a biotechnology company. The Company discovers and develops a type of orally available small molecule drugs, called allosteric modulators, to treat a broad range of diseases.
| Andre J MuellerChairman | Vincent LawtonVice Chairman |
| Bharatt M ChowriraPresident/CEO | Tim DyerCFO/Co-Founder |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page